Pfizer's Bourla Urges Patience As COVID-19 Vaccine Data Timeline Lags

 
• By Jessica Merrill

Highly anticipated data from Pfizer's Phase III COVID-19 vaccine trial does not appear on track to be made publicly available in October as previously expected.

Hourglass with sun light background
Investors and the public will need to keep waiting for COVID-19 vaccine data • Source: Shutterstock

More from COVID-19

More from Scrip